Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
545 SEK | -0.09% | -2.68% | +1.30% |
23/05 | Camurus' Rare Growth Disorder Drug Accepted for Review in EU | MT |
23/05 | Camurus Receives EMA Acceptance of MAA Filing for Octreotide SC Depot for the Treatment of Acromegaly | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.30% | 298.08Cr | |
+38.59% | 73TCr | |
-7.89% | 35TCr | |
+15.66% | 32TCr | |
+0.24% | 27TCr | |
+13.47% | 24TCr | |
+7.19% | 20TCr | |
-6.26% | 20TCr | |
+4.23% | 16TCr | |
-1.70% | 16TCr |
- Stock Market
- Equities
- CAMX Stock
- News Camurus AB
- Camurus' : CFO Steps Down